Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours ยท Estimated delivery Aug 8 - Aug 13
Key Innovation: The addition of a C18 fatty diacid side chain extends its half-life to approximately 7 days, enabling once-weekly dosing similar to modern GLP-1 receptor agonists
Retatrutide is still in the middle of its phase 3 trial program
By completing your purchase, you acknowledge that this compound is an investigational material not approved for general medical or therapeutic use by any regulatory authority
We can help you compare NAD+ IV, B12 support, and mobile IV services without turning the decision into guesswork
Saxenda is taken once a day, and it should start working within 1 to 2 days
TRIUMPH program overview The TRIUMPH clinical development program includes multiple large-scale trials designed to confirm the Phase 2 findings in broader, more diverse populations
